Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...
Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...
The Canadian Press on MSN26m
Rogers has most reliable cell network, Bell and Telus top for download speeds: reportA new report analyzing cellular connectivity experiences by customers of Canada's Big 3 providers says Rogers remains the ...
Poor physical performance in patients with non-Hodgkin lymphoma receiving CAR T-cell therapy was linked to worse survival and ...
Gipson cites safety concerns, as well as concerns that the tower will take up valuable event and parking space.
More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...
The addition of epcoritamab-bysp to standard chemotherapy significantly improved response and survival for patients with ...
A consumer who used her Cell C account for international roaming got a nasty surprise when she received a bill almost three ...
C3i Center (C3i) announces that it has obtained regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback